Oppenheimer downgraded Inspire Medical (INSP) to Perform from Outperform.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on INSP:
- Inspire Medical price target lowered to $145 from $160 at Wells Fargo
- Inspire Medical Systems Issues Strong Preliminary 2025 Revenue Results
- Inspire Medical names Matt Osberg as new CFO
- Inspire Medical sees Q4 revenue $268.9M-$269.1M, consensus $262.3M
- Inspire Medical sees FY26 revenue $1.003B-$1.013B, consensus $1B